Australia markets open in 50 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6600-0.0100 (-0.60%)
At close: 02:56PM EST
1.7000 0.00 (0.00%)
After hours: 04:00PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1011
Avg. Estimate-0.530-2.58-1.23
Low estimate-0.530-2.58-1.23
High estimate-0.530-2.58-1.23
Year ago EPS-0.72-0.84-3.24-2.58
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1011
Avg. Estimate900kN/A2.61M6.57M
Low estimate900kN/A2.61M6.57M
High estimate900kN/A2.61M6.57M
Year ago sales360kN/A1.62M2.61M
Sales growth (year/est)150.00%N/A61.10%151.70%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.96-0.48-0.6-0.66
Actual EPS-0.72-0.84-0.71-0.6
Difference0.24-0.36-0.110.06
Surprise %25.00%-75.00%-18.30%9.10%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.530-2.58-1.23
7 days ago-0.530-2.58-1.23
30 days ago-0.570-2.68-1.01
60 days ago-0.570-2.68-1.01
90 days ago-0.570-2.68-1.01
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.26.40%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year20.40%N/AN/AN/A
Next year52.30%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A